{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:50:06Z","timestamp":1791348606098,"version":"4.3.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["09\/1131(23330)\/2025-EMR-1"],"award-info":[{"award-number":["09\/1131(23330)\/2025-EMR-1"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.xphs.2026.104502","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T09:45:22Z","timestamp":1789119922000},"page":"104502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intranasal delivery of sertraline hydrochloride enhanced brain concentration and antidepressant activity: A comparative pharmacokinetic and pharmacodynamic study"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9871-392X","authenticated-orcid":false,"given":"Rajshekher","family":"Upadhyay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2111-7763","authenticated-orcid":false,"given":"Sailesh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6307-0055","authenticated-orcid":false,"given":"Rohit","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bani Kumar","family":"Jana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5731-0435","authenticated-orcid":false,"given":"Bhaskar","family":"Mazumder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2639-9588","authenticated-orcid":false,"given":"D.Ravi Sankara","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5023-1315","authenticated-orcid":false,"given":"Honey","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9431-2096","authenticated-orcid":false,"given":"Madhuri","family":"Desavathu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.xphs.2026.104502_bib0001","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41572-023-00454-1","article-title":"Major depressive disorder","volume":"9","author":"Marx","year":"2023","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.xphs.2026.104502_bib0002","doi-asserted-by":"crossref","first-page":"9529","DOI":"10.1038\/s41598-025-93923-4","article-title":"Accelerated global burden of depressive disorders during the COVID-19 pandemic from 2019 to 2021","volume":"15","author":"Zhou","year":"2025","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.xphs.2026.104502_bib0003","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1186\/s12888-024-06419-2","article-title":"Global trends in depressive disorder prevalence and DALYs among young populations: a comprehensive analysis from 1990 to 2021","volume":"24","author":"Yang","year":"2024","journal-title":"BMC Psychiatry"},{"issue":"11","key":"10.1016\/j.xphs.2026.104502_bib0004","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.18203\/2394-6040.ijcmph20253726","article-title":"Antidepressant medications: a comprehensive review of efficacy, safety, and future directions","volume":"12","author":"Shah","year":"2025","journal-title":"Int J Community Med Public Health"},{"issue":"1","key":"10.1016\/j.xphs.2026.104502_bib0005","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006117.pub4","article-title":"Sertraline versus other antidepressive agents for depression","author":"Cipriani","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.xphs.2026.104502_bib0006","series-title":"Sertraline hydrochloride. Analytical profiles of Drug Substances and excipients. 24","first-page":"443","author":"Johnson","year":"1996"},{"key":"10.1016\/j.xphs.2026.104502_bib0007","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejpb.2023.12.002","article-title":"Intranasal administration of sertraline ensures sustained brain delivery and antidepressant effect in a mouse model of depression","volume":"194","author":"Silva","year":"2024","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2026.104502_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106653","article-title":"Investigation into the impact of proton pump inhibitors on sertraline transport across the blood-brain barrier","volume":"194","author":"Xiao","year":"2024","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2026.104502_bib0009","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1476-5381.2011.01557.x","article-title":"Interactions between antidepressants and P-glycoprotein at the blood\u2013brain barrier: clinical significance of in vitro and in vivo findings","volume":"165","author":"O'Brien","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.xphs.2026.104502_bib0010","first-page":"1","article-title":"Intranasal delivery route for neurodegenerative diseases: recent insights and future directions","author":"Correale","year":"2025","journal-title":"Drug Deliv Transl Res"},{"issue":"3","key":"10.1016\/j.xphs.2026.104502_bib0011","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70190","article-title":"The impact of P-glycoprotein on CNS drug efflux and variability in response","volume":"39","author":"Paul","year":"2025","journal-title":"J Biochem Mol Toxicol"},{"issue":"6","key":"10.1016\/j.xphs.2026.104502_bib0012","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1080\/17425247.2025.2489553","article-title":"The nasal route for nose-to-brain drug delivery: advanced nasal formulations for CNS disorders","volume":"22","author":"Papakyriakopoulou","year":"2025","journal-title":"Expert Opin Drug Deliv"},{"issue":"6","key":"10.1016\/j.xphs.2026.104502_bib0013","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70213","article-title":"The Nasal\u2013brain drug delivery route: mechanisms and applications to central nervous system diseases","volume":"6","author":"Qiu","year":"2025","journal-title":"MedComm"},{"issue":"1","key":"10.1016\/j.xphs.2026.104502_bib0014","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1039\/D5NR02259B","article-title":"Overcoming barriers: nanomedicine-based strategies for nose-to-brain delivery","volume":"18","author":"Paraiso","year":"2026","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.xphs.2026.104502_bib0015","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s40005-022-00589-5","article-title":"Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors","volume":"53","author":"Jeong","year":"2023","journal-title":"J pharm investig"},{"issue":"2","key":"10.1016\/j.xphs.2026.104502_bib0016","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/00914037.2022.2124255","article-title":"A comprehensive review on carrier mediated nose to brain targeting: emphasis on molecular targets, current trends, future prospects, and challenges","volume":"73","author":"Tomar","year":"2024","journal-title":"Int j polym mater polym biomater"},{"issue":"2","key":"10.1016\/j.xphs.2026.104502_bib0017","article-title":"Direct nose to the brain nanomedicine delivery presents a formidable challenge","volume":"14","author":"Yokel","year":"2022","journal-title":"Wiley Interdiscip Rev: Nanomed Nanobiotechnol"},{"issue":"5","key":"10.1016\/j.xphs.2026.104502_bib0018","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1208\/s12249-024-02810-0","article-title":"In-depth mechanism, challenges, and opportunities of delivering therapeutics in brain using intranasal route","volume":"25","author":"Ghosh","year":"2024","journal-title":"AAPS PharmSciTech"},{"issue":"11","key":"10.1016\/j.xphs.2026.104502_bib0019","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11051-023-05880-6","article-title":"Brain targeting of drugs via intranasal route in conjunction with nanoparticle-based systems: an updated review","volume":"25","author":"Furquan","year":"2023","journal-title":"J Nanoparticle Res"},{"issue":"1","key":"10.1016\/j.xphs.2026.104502_bib0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.12923\/cipms-2025-0002","article-title":"Solid lipid nanoparticle a complete tool for brain targeted drug delivery","volume":"38","author":"Ramalingam","year":"2025","journal-title":"Curr Issues Pharm Med Sci"},{"issue":"3","key":"10.1016\/j.xphs.2026.104502_bib0021","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3390\/pharmaceutics14030572","article-title":"Pharmacokinetics and pharmacodynamics of intranasal solid lipid nanoparticles and nanostructured lipid carriers for nose-to-brain delivery","volume":"14","author":"Nguyen","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2026.104502_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1214450","article-title":"Lipid-based nanoparticles via nose-to-brain delivery: a mini review","volume":"11","author":"Xinchen","year":"2023","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104502_bib0023","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12088-024-01304-8","article-title":"Mucus-penetrating PEGylated nanoshuttle for enhanced drug delivery and healthcare applications","volume":"65","author":"Bain","year":"2025","journal-title":"Indian J Microbiol"},{"key":"10.1016\/j.xphs.2026.104502_bib0024","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.addr.2017.08.010","article-title":"PEGylation for enhancing nanoparticle diffusion in mucus \u2606","volume":"124","author":"Lai","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"issue":"7","key":"10.1016\/j.xphs.2026.104502_bib0025","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.3390\/ijms26073102","article-title":"The art of PEGylation: from simple polymer to sophisticated drug delivery system","volume":"26","author":"Makharadze","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.xphs.2026.104502_bib0026","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1021\/acsptsci.5c00560","article-title":"Intranasal sertraline for the investigation of nose-to-brain delivery to mitigate systemic exposure","volume":"8","author":"Williams","year":"2025","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.xphs.2026.104502_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124866","article-title":"Advancement in the nose-to-brain drug delivery of FDA-approved drugs for the better management of depression and psychiatric disorders","volume":"667","author":"Upadhyay","year":"2024","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2026.104502_bib0028","doi-asserted-by":"crossref","first-page":"7323","DOI":"10.2147\/IJN.S525759","article-title":"Advancements in nanotherapeutics for the treatment of depression via intranasal pathway: a review","volume":"Volume 20","author":"Patel","year":"2025","journal-title":"Int J Nanomed"},{"issue":"6","key":"10.1016\/j.xphs.2026.104502_bib0029","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1007\/s13346-020-00816-2","article-title":"Nose-to-brain drug delivery mediated by polymeric nanoparticles: influence of PEG surface coating","volume":"10","author":"de Oliveira Junior","year":"2020","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.xphs.2026.104502_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119088","article-title":"Exploration of docetaxel palmitate and its solid lipid nanoparticles as a novel option for alleviating the rising concern of multi-drug resistance","volume":"578","author":"Kaushik","year":"2020","journal-title":"Int J Pharm"},{"issue":"8","key":"10.1016\/j.xphs.2026.104502_bib0031","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1039\/C9RA10857B","article-title":"PLGA nanoparticle preparations by emulsification and nanoprecipitation techniques: effects of formulation parameters","volume":"10","author":"Hern\u00e1ndez-Giottonini","year":"2020","journal-title":"RSC Adv"},{"key":"10.1016\/j.xphs.2026.104502_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.inoche.2024.113737","article-title":"Investigating in-depth potential of lipid-engineered emulsomes of aceclofenac for the management of arthritis: a comprehensive preclinical study","volume":"172","author":"Sharma","year":"2025","journal-title":"Inorg Chem Commun"},{"issue":"3","key":"10.1016\/j.xphs.2026.104502_bib0033","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3390\/ph15030370","article-title":"Design and development of Levodopa loaded polymeric nanoparticles for intranasal delivery","volume":"15","author":"Ahmad","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"7","key":"10.1016\/j.xphs.2026.104502_bib0034","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1208\/s12249-024-02955-y","article-title":"Docetaxel-tethered di-carboxylic acid derivatised fullerenes: a promising drug delivery approach for breast cancer","volume":"25","author":"Misra","year":"2024","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.xphs.2026.104502_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119776","article-title":"Chitosan-coated PLGA nanoparticles for the nasal delivery of ropinirole hydrochloride: in vitro and ex vivo evaluation of efficacy and safety","volume":"589","author":"Chatzitaki","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2026.104502_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2023.123827","article-title":"A simple and sensitive LC-MS\/MS method for the quantitation of sertraline and N-desmethylsertraline in human plasma","volume":"1228","author":"Phogole","year":"2023","journal-title":"J Chromatogr B"},{"issue":"11","key":"10.1016\/j.xphs.2026.104502_bib0037","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2217\/nnm-2023-0229","article-title":"Compritol(\u00ae)-based solid lipid nanoparticles of desvenlafaxine prepared by ultrasonication-assisted hot-melt encapsulation to modify its release","volume":"19","author":"Rao","year":"2024","journal-title":"Nanomed (L)"},{"issue":"3","key":"10.1016\/j.xphs.2026.104502_bib0038","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel","volume":"99","author":"Zhang","year":"2010","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.xphs.2026.104502_bib0039","doi-asserted-by":"crossref","unstructured":"Marongiu R, Marciano S. Sucrose preference test. 2026.","DOI":"10.17504\/protocols.io.5jyl8x5xdv2w\/v1"},{"issue":"59","key":"10.1016\/j.xphs.2026.104502_bib0040","first-page":"3638","article-title":"The mouse forced swim test","author":"Can","year":"2012","journal-title":"J Vis Exp: JoVE"},{"issue":"59","key":"10.1016\/j.xphs.2026.104502_bib0041","first-page":"3769","article-title":"The tail suspension test","author":"Can","year":"2012","journal-title":"J Vis Exp: JoVE"},{"issue":"10","key":"10.1016\/j.xphs.2026.104502_bib0042","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.3109\/13880209.2014.991837","article-title":"A validated HPLC-UV method and optimization of sample preparation technique for norepinephrine and serotonin in mouse brain","volume":"53","author":"Thomas","year":"2015","journal-title":"Pharm Biol"},{"issue":"3","key":"10.1016\/j.xphs.2026.104502_bib0043","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1208\/s12249-010-9487-8","article-title":"Optimization of PEGylation conditions for BSA nanoparticles using response surface methodology","volume":"11","author":"Kouchakzadeh","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.xphs.2026.104502_bib0044","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jconrel.2016.06.017","article-title":"DLS and zeta potential \u2013 What they are and what they are not?","volume":"235","author":"Bhattacharjee","year":"2016","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.xphs.2026.104502_bib0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/colloids7010015","article-title":"Dynamic light scattering: a powerful tool for In situ nanoparticle sizing","volume":"7","author":"Jia","year":"2023","journal-title":"Colloids Interfaces"},{"issue":"5","key":"10.1016\/j.xphs.2026.104502_bib0046","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3390\/ph18050615","article-title":"Advancements in nanocarrier systems for nose-to-brain drug delivery","volume":"18","author":"Nguyen","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"Pt A","key":"10.1016\/j.xphs.2026.104502_bib0047","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2026.104502_bib0048","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"issue":"null","key":"10.1016\/j.xphs.2026.104502_bib0049","first-page":"5503","article-title":"Effects of PEGylated lipid nanoparticles on the oral absorption of one BCS II drug: a mechanistic investigation","volume":"9","author":"Zhang","year":"2014","journal-title":"Int J Nanomed"},{"issue":"2","key":"10.1016\/j.xphs.2026.104502_bib0050","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0939-6411(03)00193-0","article-title":"Comparison of scanning electron microscopy, dynamic light scattering and analytical ultracentrifugation for the sizing of poly(butyl cyanoacrylate) nanoparticles","volume":"57","author":"Bootz","year":"2004","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"10.1016\/j.xphs.2026.104502_bib0051","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.3390\/molecules19022445","article-title":"Preparation and in vitro evaluation of glycyrrhetinic acid-modified curcumin-loaded nanostructured lipid carriers","volume":"19","author":"Chu","year":"2014","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.xphs.2026.104502_bib0052","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.3390\/pharmaceutics14091821","article-title":"Preparation, characterization, and biological evaluation of a hydrophilic peptide loaded on PEG-PLGA nanoparticles","volume":"14","author":"Marinelli","year":"2022","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.xphs.2026.104502_bib0053","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1021\/acs.bioconjchem.5c00062","article-title":"Mannosamine-modified poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles for the targeted delivery of rifapentine and isoniazid in tuberculosis therapy","volume":"36","author":"Peng","year":"2025","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.xphs.2026.104502_bib0054","first-page":"55","article-title":"Cytotoxic effects of gemcitabine-loaded solid lipid nanoparticles in pancreatic cancer cells","author":"Affram","year":"2020","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.xphs.2026.104502_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119088","article-title":"Exploration of docetaxel palmitate and its solid lipid nanoparticles as a novel option for alleviating the rising concern of multi-drug resistance","volume":"578","author":"Kaushik","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2026.104502_bib0056","article-title":"Release mechanisms of PLGA-based drug delivery systems: a review","volume":"10","author":"Siepmann","year":"2025","journal-title":"Int J Pharm: X"},{"key":"10.1016\/j.xphs.2026.104502_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125166","article-title":"PEGylated solid lipid nanoparticles for the intranasal delivery of combination antiretroviral therapy composed of Atazanavir and Elvitegravir to treat NeuroAIDS","volume":"670","author":"Bazargani","year":"2025","journal-title":"Int J Pharm"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:54:24Z","timestamp":1791345264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926003527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":57,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0022354926003527"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104502","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal delivery of sertraline hydrochloride enhanced brain concentration and antidepressant activity: A comparative pharmacokinetic and pharmacodynamic study","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104502","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104502"}}